Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10097387 | European Journal of Radiology | 2005 | 6 Pages |
Abstract
In patients with recurrent ovarian cancer, PET/CT detects more lesions than PET or CT alone. PET/CT permits the exact anatomical localisation of pathologic tracer uptake and can thus direct further treatment to the precise site of tumour recurrence. Hence, PET/CT should be considered for follow-up of patients with ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Elke A.M. Hauth, Gerald Antoch, Joerg Stattaus, Hilmar Kuehl, Patrick Veit, Andreas Bockisch, Rainer Kimmig, Michael Forsting,